republic-os/legislation/us/states/ny/2023-2024/a-6799.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Establishes a drug-induced movement disorder screening education program	Establishes a drug-induced movement disorder screening education program; provides that the department shall develop such program to educate the public about the importance of screening for drug-induced movement disorders, develop and disseminate educational materials for healthcare providers regarding treatment for drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions.	us/states/ny	New York Legislature	2023-2024	A 6799	New York A 6799 (2023-2024)	bill		enacted	Amy Paulin	3	21	2	2023-05-08	2024-12-21	openstates	ocd-bill/c78e9d9e-8586-4b86-abb8-1c90222767ad	http://www.nysenate.gov/legislation/bills/2023/A6799	4016b2c1c7bdcf0da1ba19bb980a3b321f39a5b8573b628a26450c7cfbf46a20	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-ny

New York A 6799 (2023-2024) — Establishes a drug-induced movement disorder screening education program

Establishes a drug-induced movement disorder screening education program; provides that the department shall develop such program to educate the public about the importance of screening for drug-induced movement disorders, develop and disseminate educational materials for healthcare providers regarding treatment for drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. A6799 (committee substitute) — source
2. A6799A (committee substitute) — source
3. A6799B (committee substitute) — source

Votes

• Assembly Vote — 145–0 (pass) · lower
• Floor Vote - Version: B — 61–0 (pass) · upper

Sponsors

• Amy Paulin — primary (person)
• Nader Sayegh — cosponsor (person)
• Rebecca Seawright — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2023-05-08 REFERRED TO HEALTH referral-committee
• 2023-12-08 AMEND AND RECOMMIT TO HEALTH amendment-passage, referral-committee
• 2023-12-08 PRINT NUMBER 6799A amendment-passage
• 2024-01-03 REFERRED TO HEALTH referral-committee
• 2024-01-17 REPORTED REFERRED TO WAYS AND MEANS referral-committee
• 2024-04-12 AMEND AND RECOMMIT TO WAYS AND MEANS amendment-passage, referral-committee
• 2024-04-12 PRINT NUMBER 6799B amendment-passage
• 2024-05-28 REPORTED REFERRED TO RULES referral-committee
• 2024-05-30 REPORTED
• 2024-05-30 RULES REPORT CAL.244
• 2024-05-30 ORDERED TO THIRD READING RULES CAL.244
• 2024-05-30 PASSED ASSEMBLY passage
• 2024-05-30 DELIVERED TO SENATE
• 2024-05-30 REFERRED TO HEALTH referral-committee
• 2024-06-06 SUBSTITUTED FOR S8965A
• 2024-06-06 3RD READING CAL.838
• 2024-06-06 PASSED SENATE passage
• 2024-06-06 RETURNED TO ASSEMBLY
• 2024-12-12 DELIVERED TO GOVERNOR executive-receipt
• 2024-12-21 SIGNED CHAP.616 executive-signature
• 2024-12-21 APPROVAL MEMO.56

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/c78e9d9e-8586-4b86-abb8-1c90222767ad. Confidence: reported (aggregated from official New York legislature records).